← Back to Clinical Trials
Recruiting NCT06203938
NCT06203938 Autism Research Project With Non-Invasive Near-Infrared Light Stimulation
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT06203938 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Texas at Austin |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 280 participants |
| Start Date | 2025-01-13 |
| Primary Completion | 2027-12 |
Trial Parameters
Condition Autism Spectrum Disorder
Sponsor University of Texas at Austin
Study Type INTERVENTIONAL
Phase N/A
Enrollment 280
Sex ALL
Min Age 4 Years
Max Age 60 Years
Start Date 2025-01-13
Completion 2027-12
Interventions
Transcranial infrared light stimulationSham
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The investigators have previously shown that the administration of low-level infrared light is a safe and non-invasive procedure which improves cognition and emotion, as well as enhances brain metabolic activity. Based on previous studies, the investigators hypothesize that this methodology, called low-level light therapy or photobiomodulation, could be used to improve behavioral symptoms in individuals with autism spectrum disorder (ASD).
Eligibility Criteria
Inclusion Criteria: * Age between 4-60 years Exclusion Criteria: * Current pregnancy
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology